Evidence of EGR1 as a differentially expressed gene among proliferative skin diseases

Genomic Medicine

Volumn 1, Issue 1-2, 2007, Pages 75-85

  Fang, Min ^a   Wee, Sue Ann ^b   Ronski, Karyn ^a   Fan, Hongran ^b   Tao, Shiying ^b   Lin, Qun ^b  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; EGR1; Epidermis; Gene expression; Psoriasis

Indexed keywords

EID: 34548222087     PISSN: 18717934     EISSN: 18717942     Source Type: Journal    
DOI: 10.1007/s11568-007-9010-9     Document Type: Article

References (43)

1. Bale AE, Yu KP (2001) The hedgehog pathway and basal cell carcinomas. Hum Mol Genet 10:757-762
2. Barbosa MS, Schlegel R (1989) The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4:1529-1532
3. Byrne C, Fuchs E (1993) Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice. Mol Cell Biol 13:3176-3190
4. Capon F, Dallapiccola B, Novelli G (2000) Advances in the search for psoriasis susceptibility genes. Mol Genet Metab 71:250-255
5. Choate KA, Medalie DA, Morgan JR, Khavari PA (1996) Corrective gene transfer in the human skin disorder lamellar ichthyosis. Nat Med 2:1263-1267
6. Dajee M, Lazarov M, Zhang JY, Cai T, Green CL, Russell AJ, Marinkovich MP, Tao S, Lin Q, Kubo Y, Khavari PA (2003) NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 421:639-643
7. Deng H, Choate KA, Lin Q, Khavari PA (1998) High-efficiency gene transfer and pharmacologic selection of genetically engineered human keratinocytes. Biotechniques 25:274-280
8. Dong G, Loukinova E, Chen Z, Gangi L, Chanturita TI, Liu ET, Van Waes C (2001) Molecular profiling of transformed and metastatic murine squamous carcinoma cells by differential display and cDNA microarray reveals altered expression of multiple genes related to growth, apoptosis, angiogenesis, and the NF-kappaB signal pathway. Cancer Res 61:4797-4808
9. Eisen MB, Spellman PT, Brown PO, Botstein D (1998) Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A 95:14863-14868
10. Fairman J, Chumakov I, Chinault AC, Nowell PC, Nagarajan L (1995) Physical mapping of the minimal region of loss in 5q- chromosome. Proc Natl Acad Sci U S A 92:7406-7410
11. Galaktionov K, Chen X, Beach D (1996) Cdc25 cell-cycle phosphatase as a target of c-myc. Nature 382:511-517
12. Gashler AL, Swaminathan S, Sukhatme VP (1993) A novel repression module, an extensive activation domain, and a bipartite nuclear localization signal defined in the immediate-early transcription factor Egr-1. Mol Cell Biol 13:4556-4571
13. Gasparotto D, Maestro R, Piccinin S, Vukosavljevic T, Barzan L, Sulfaro S, Boiocchi M (1997) Overexpression of Cdc25A and CDC25B in head and neck cancers. Cancer Res 57:2366-2368
14. Hao MW, Liang YR, Liu YF, Liu L, Wu MY, Yang HX (2002) Transcription factor Egr-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J Gastroenterol 8:203-207
15. Huang RP, Darland T, Okamura D, Mercola D, Adamson ED (1994) Suppression of v-sis-dependent transformation by the transcription factor, Egr-1. Oncogene 9:1367-1377
16. Huang RP, Fan Y, de Belle I, Niemeyer C, Gottardis MM, Mercola D, Adamson ED (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation. Int J Cancer 72:102-109
17. Huang RP, Liu C, Fan Y, Mercola D, Adamson ED (1995) Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain. Cancer Res 55:5054-5062
18. Kinsella TM, Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 7:1405-1413
19. Kobayashi D, Yamada M, Kamagata C, Kaneko R, Tsuji N, Nakamura M, Yagihashi A, Watanabe N (2002) Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res 22:3963-3970
20. Kore-eda S, Horiguchi Y, Ueda M, Toda K, Imamura S (1998) Basal cell carcinoma cells resemble follicular matrix cells rather than follicular bulge cells: immunohistochemical and ultrastructural comparative studies. Am J Dermatopathol 20:362-369
21. Krones-Herzig A, Mittal S, Yule K, Liang H, English C, Urcis R, Soni T, Adamson ED, Mercola D (2005) Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res 65:5133-5143
22. Kuhajda FP, Pizer ES, Li JN, Mani NS, Frehywot GL, Townsend CA (2000) Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci U S A 97:3450-3454
23. Levin WJ, Press MF, Gaynor RB, Sukhatme VP, Boone TC, Reissmann PT, Figlin RA, Holmes EC, Souza LM, Slamon DJ (1995) Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group. Oncogene 11:1261-1269
24. Marionnet C, Lalou C, Mollier K, Chazal M, Delestaing G, Compan D, Verola O, Vilmer C, Cuminet J, Dubertret L, Basset-Seguin N (2003) Differential molecular profiling between skin carcinomas reveals four newly reported genes potentially implicated in squamous cell carcinoma development. Oncogene 22:3500-3505
25. Mercurio AM (2003) Invasive skin carcinoma-Ras and alpha6beta4 integrin lead the way. Cancer Cell 3:201-202
26. Miller DL, Weinstock MA (1994) Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 30:774-778
27. Nilsson I, Hoffmann I (2000) Cell cycle regulation by the Cdc25 phosphatase family. Prog Cell Cycle Res 4:107-114
28. Nomura I, Gao B, Boguniewicz M, Darst MA, Travers JB, Leung DY (2003) Distinct patterns of gene expression in the skin lesions of atopic dermatitis and psoriasis: a gene microarray analysis. J Allergy Clin Immunol 112:1195-1202
29. O'Connor DP, Kay EW, Leader M, Murphy GM, Atkins GJ, Mabruk MJ (2001) A high degree of chromosomal instability at 13q14 in cutaneous squamous cell carcinomas: indication for a role of a tumour suppressor gene other than Rb. Mol Pathol 54:165-169
30. Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG, Trepicchio WL (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1:272-287
31. Postel EH, Abramczyk BM, Levit MN, Kyin S (2000) Catalysis of DNA cleavage and nucleoside triphosphate synthesis by NM23-H2/NDP kinase share an active site that implies a DNA repair function. Proc Natl Acad Sci U S A 97:14194-14199
32. Quinn AG, Sikkink S, Rees JL (1994) Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 54:4756-4759
33. Ragione FD, Cucciolla V, Criniti V, Indaco S, Borriello A, Zappia V (2003) p21Cip1 gene expression is modulated by EGR1: a novel regulatory mechanism involved in the resveratrol antiproliferative effect. J Biol Chem 278:23360-23368
34. Rheinwald JG, Beckett MA (1981) Tumorigenic keratinocyte lines requiring anchorage and fibroblast support cultures from human squamous cell carcinomas. Cancer Res 41:1657-1663
35. Riggs PK, Rho O, DiGiovanni J (2000) Alteration of Egr-1 mRNA during multistage carcinogenesis in mouse skin. Mol Carcinog 27:247-251
36. Ronski K, Sanders M, Burleson J, Benn P, Fang M (2005) EGR1 gene is deleted in estrogen receptor-negative human breast cancer. Cancer 104:925-930
37. Tennenbaum T, Belanger AJ, Quaranta V, Yuspa SH (1996) Differential regulation of integrins and extracellular matrix binding in epidermal differentiation and squamous tumor progression. J Investig Dermatol Symp Proc 1:157-161
38. Thigpen AE, Cala KM, Guileyardo JM, Molberg KH, McConnell JD, Russell DW (1996) Increased expression of early growth response-1 messenger ribonucleic acid in prostatic adenocarcinoma. J Urol 155:975-981
39. Uchiyama N, Yamamoto A, Kameda K, Yamaguchi H, Ito M (2000) The activity of fatty acid synthase of epidermal keratinocytes is regulated in the lower stratum spinousum and the stratum basale by local inflammation rather than by circulating hormones. J Dermatol Sci 24:134-141
40. Wang XJ, Liefer KM, Tsai S, O'Malley BW, Roop DR (1999) Development of gene-switch transgenic mice that inducibly express transforming growth factor beta1 in the epidermis. Proc Natl Acad Sci U S A 96:8483-8488
41. Welss T, Papoutsaki M, Michel G, Reifenberger J, Chimenti S, Ruzicka T, Abts HF (2003) Molecular basis of basal cell carcinoma: analysis of differential gene expression by differential display PCR and expression array. Int J Cancer 104:66-72
42. Xie J, Aszterbaum M, Zhang X, Bonifas JM, Zachary C, Epstein E, McCormick F (2001) A role of PDGFRalpha in basal cell carcinoma proliferation. Proc Natl Acad Sci U S A 98:9255-9259
43. Zhou X, Krueger JG, Kao MC, Lee E, Du F, Menter A, Wong WH, Bowcock AM (2003) Novel mechanisms of T-cell and dendritic cell activation revealed by profiling of psoriasis on the 63,100-element oligonucleotide array. Physiol Genomics 13:69-78